Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer
Yingke Zhou, Xin Jin, Haixin Yu, et al.
Theranostics (2022) Vol. 12, Iss. 5, pp. 2080-2094
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Advances in targeting histone deacetylase for treatment of solid tumors
Mu-Qi Shi, Ying Xu, Xin Fu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Current insight into the regulation of PD-L1 in cancer
Zhuandi Liu, Xibao Yu, Ling Xu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 63
The protective activity of natural flavonoids against osteoarthritis by targeting NF-κB signaling pathway
Yongjun Ye, Jianguo Zhou
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expression
Xinwei Qiao, Zaixing Cheng, Kaming Xue, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 23
Iridium(III)-Based PD-L1 Agonist Regulates p62 and ATF3 for Enhanced Cancer Immunotherapy
Dongping Deng, Mengmeng Wang, Yan Su, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6810-6821
Closed Access | Times Cited: 9
Anticancer properties of histone deacetylase inhibitors – what is their potential?
Kajetan Kiełbowski, Agata Szwedkowicz, Paulina Plewa, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-16
Closed Access | Times Cited: 1
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention
Rahma K. Alseksek, Wafaa S. Ramadan, Ekram Saleh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8141-8141
Open Access | Times Cited: 32
Integrated single-cell and bulk RNA sequencing revealed the molecular characteristics and prognostic roles of neutrophils in pancreatic cancer
Biao Zhang, Jiaao Sun, Hewen Guan, et al.
Aging (2023) Vol. 15, Iss. 18, pp. 9718-9742
Open Access | Times Cited: 21
NF-κB in Cell Deaths, Therapeutic Resistance and Nanotherapy of Tumors: Recent Advances
Xuesong Wu, Liang Sun, Fangying Xu
Pharmaceuticals (2023) Vol. 16, Iss. 6, pp. 783-783
Open Access | Times Cited: 18
Isorhamnetin: what is the in vitro evidence for its antitumor potential and beyond?
Jiaming Lei, Jianbao Yang, Cuiyu Bao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Post-translational modifications of p65: state of the art
Xutao Sun, Shuo Cao, Caiyun Mao, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 4
Pancreatic ductal adenocarcinoma cells reshape the immune microenvironment: Molecular mechanisms and therapeutic targets
Yutong Zhao, C.M. Qin, Lin Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189183-189183
Closed Access | Times Cited: 4
Challenges in immunotherapy for PDAC: Overcoming immune resistance and enhancing treatment strategies
Seema Kumari, Ganji Purnachandra Nagaraju
Elsevier eBooks (2025), pp. 191-198
Closed Access
Discovery of Novel Hydrazide-Based HDAC3 Inhibitors as Epigenetic Immunomodulators for Cancer Immunotherapy
Zhiqiang Sun, Jinmei Cheng, Chenglong Xu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer
Tingting Qin, Jingya Wang, Jian Wang, et al.
Advanced Science (2025)
Open Access
HDAC inhibitors and IBD: Charting new approaches in disease management
Xueting Du, Weilai Yu, Fangyu Chen, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114193-114193
Closed Access
Nerve Infiltration of Bladder Cancer Predicts Response to Immunotherapy
Xinyi Lü, Kun-Ming Shui, Hao Ji, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151687-151687
Closed Access
Analysis of mutually exclusive expression in cancer cells identifies a previously unknown intergenic regulatory paradigm
Ling Tang, Yuzhe Hu, Chao Wang, et al.
FEBS Journal (2025)
Closed Access
Mechanisms of HDACs in cancer development
Ying Zhang, Haotian Wang, Zhumei Zhan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
HDAC4 Super-Enhancer Drives CEBPB-Mediated TWIST2 Transcription to Promote Chemoresistance in LUAD
Min Jiang, Kai Zhang, Guohao Wei, et al.
Cancer Letters (2025), pp. 217716-217716
Closed Access
SIK1 promotes ferroptosis resistance in pancreatic cancer via HDAC5-STAT6-SLC7A11 axis
Hao Zhang, Tao Ma, Xiaofeng Wen, et al.
Cancer Letters (2025), pp. 217726-217726
Closed Access
YEATS2: a novel cancer epigenetic reader and potential therapeutic target
Kangkang Ji, Guoping Chen, Bin Wang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Acetylation and deacetylation dynamics in stress response to cancer and infections
Lili Li, Yanqiong Zeng, Genhong Cheng, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101957-101957
Closed Access
Histone Modifications Represent a Key Epigenetic Feature of Epithelial-to-Mesenchyme Transition in Pancreatic Cancer
Ying Xu, Qing Zhu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4820-4820
Open Access | Times Cited: 9
The regulatory relationship between NAMPT and PD-L1 in cancer and identification of a dual-targeting inhibitor
Yuan Yang, Zefei Li, Yidong Wang, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 4, pp. 885-903
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top